Long-term survival with anti-PD-1-based immunotherapy, but what is the best approach?

Similar Items

• An affinity threshold for maximum efficacy in anti-PD-1 immunotherapy
  by: Cowles, Sarah C., et al.
  Published: (2022)
• An Affinity Threshold for Maximum Efficacy in Anti-PD-1 Cancer Immunotherapy
  by: Cowles, Sarah Clare
  Published: (2022)
• Uncoupling immune trajectories of response and adverse events from anti-PD-1 immunotherapy in hepatocellular carcinoma
  by: Chuah, Samuel, et al.
  Published: (2022)
• Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model
  by: Philippou, Y, et al.
  Published: (2020)
• What treatments for rheumatoid arthritis can best be assessed by large, simple, long-term trials?
  by: Peto, R
  Published: (1983)